Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2013-07-06
2014-08-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Certain Breakfasts on Appetite Control
NCT02111486
Snacking, Satiety &Weight: A Randomized, Controlled Trial
NCT02050165
Effects of Pecan Nut Snacks v Equicaloric Snacks on Appetite, Food Intake, Metabolism, Hormones and Biomarkers
NCT04484974
A Comparison of Satiety Effects Two Commercially Available Snack Bars
NCT07227701
High Fat vs High Protein and Appetite Hormones
NCT04518930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Snack #1
One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #1 is a gluten-free high protein snack comprised of a 30g serving of buckwheat groats. The placebo comparator reference product is a gluten-free snack with similar energy density, but 1/2 the protein as snack #1, comprised of a 32g serving of corn nuts. The placebo comparator non-caloric control is water.
gluten-free high protein snack #1
buckwheat groats 30g serving
gluten-free snack with similar energy density but 1/2 the protein as snack #1
32g serving of corn nuts
non-caloric control
water
Experimental Snack #2
One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #2 is a gluten-free high protein and high fibre snack comprised of a 50g serving of a buckwheat and pinto bean flour pita bread. The placebo comparator reference product is a gluten-free snack with similar energy density, but less protein and fibre than snack #2, comprised of a 50g serving of rice bread. The placebo comparator non-caloric control is water.
non-caloric control
water
gluten-free high protein and high fibre snack #2
buckwheat and pinto bean flour pita bread 50g serving
gluten-free snack with similar energy density, but less protein and fibre than snack #2
50g serving of rice bread
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
gluten-free high protein snack #1
buckwheat groats 30g serving
gluten-free snack with similar energy density but 1/2 the protein as snack #1
32g serving of corn nuts
non-caloric control
water
gluten-free high protein and high fibre snack #2
buckwheat and pinto bean flour pita bread 50g serving
gluten-free snack with similar energy density, but less protein and fibre than snack #2
50g serving of rice bread
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* males and non-pregnant or non-lactating females
Exclusion Criteria
* Daily tobacco use.
* Physical Activity Level \>1.8.
* Eat meals at irregular or unusual times.
* Food allergy, aversion or unwillingness to eat study foods.
* Use of any prescription or non-prescription drug, herbal or nutritional supplement known to affect appetite.
* Presence of a gastrointestinal disorder.
* Score \>65% on any 1 of the 3 categories of the Three Factor Eating Questionnaire-R18.
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Manitoba Agri-Health Research Network
OTHER
St. Boniface Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Heather Blewett
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heather J Blewett, PhD
Role: PRINCIPAL_INVESTIGATOR
St. Boniface Hospital Research Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I. H. Asper Clinical Research Institute
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010 Mar;11(3):251-70. doi: 10.1111/j.1467-789X.2010.00714.x. Epub 2010 Jan 29.
Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. Am J Clin Nutr. 2008 May;87(5):1558S-1561S. doi: 10.1093/ajcn/87.5.1558S.
Belski R. Fiber, protein, and lupin-enriched foods: role for improving cardiovascular health. Adv Food Nutr Res. 2012;66:147-215. doi: 10.1016/B978-0-12-394597-6.00004-5.
Related Links
Access external resources that provide additional context or updates about the study.
Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian Institute for Health Information
Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations
Draft guidance document: Satiety health claims on food from Health Canada
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RRC/2013/1276
Identifier Type: OTHER
Identifier Source: secondary_id
H2013:036
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.